Brain Attack Stroke Hesi Case Study

You're staring at the screen. On the flip side, the clock is ticking. But the patient is 68, left-sided weakness, slurred speech, arrived 45 minutes ago. You need to pick the priority action — not the correct action, the priority action — and you have about ninety seconds before you second-guess yourself into the wrong answer That's the whole idea..

Sound familiar? That's why if you've taken a HESI exit exam or a neuro specialty test, it does. Worth adding: the "brain attack" stroke case study is one of those scenarios that shows up again and again. Not because it's tricky. Because it's the kind of clinical judgment that separates passing from failing — and more importantly, safe practice from dangerous practice It's one of those things that adds up. Worth knowing..

Let's walk through what this case study actually tests, where students trip up, and how to think like a nurse who's seen this a hundred times.

What Is a Brain Attack Stroke HESI Case Study

First, terminology. That's why "Brain attack" isn't just a dramatic synonym. If you call it a "stroke," people wait. It was coined deliberately — by the National Institute of Neurological Disorders and Stroke, back in the 90s — to make stroke feel as urgent as a heart attack. Language shapes response. If you call it a "brain attack," they call 911.

And yeah — that's actually more nuanced than it sounds It's one of those things that adds up..

In the HESI world, this case study is a simulated clinical scenario. You get a patient — usually older adult, often with atrial fibrillation or hypertension — presenting with sudden-onset neurological deficits. The case unfolds in phases: pre-hospital, ED arrival, diagnostic workup, acute management, then secondary prevention and discharge planning.

Each phase asks you to prioritize. Not "what would you do?" but "what do you do first?" That distinction is everything Worth keeping that in mind..

The Two Stroke Types You'll See

HESI loves to test both. You need to recognize the difference instantly Not complicated — just consistent..

Ischemic stroke — about 87% of cases. Thrombus or embolus blocks a cerebral vessel. The penumbra (that rim of salvageable tissue around the core infarct) is the whole game. Time is brain. tPA window. Mechanical thrombectomy window.

Hemorrhagic stroke — intracerebral or subarachnoid. Vessel ruptures. Blood irritates, compresses, displaces. tPA is contraindicated. This is where students lose points — they see "stroke" and reflexively think "give tPA." Wrong. You give tPA to the wrong patient, they bleed out.

The case study will drip-feed you clues. Sudden thunderclap headache? Think subarachnoid. Gradual stepwise deficit? Maybe thrombotic. Atrial fib on the monitor? Embolic. And uncontrolled hypertension? Intracerebral hemorrhage.

Why These Case Studies Matter for Nursing Students

Here's the thing nobody says out loud: HESI isn't testing your memory. It's testing your clinical judgment model. The NCSBN Clinical Judgment Measurement Model (CJMM) — recognize cues, analyze cues, prioritize hypotheses, generate solutions, take action, evaluate outcomes — that's the engine under the hood That's the part that actually makes a difference..

The brain attack case study hits every cylinder.

You recognize cues: facial droop, drift, aphasia, time last known well. You analyze: is this ischemic or hemorrhagic? You prioritize: airway, breathing, circulation — but also time to CT, glucose check, tPA eligibility. So you generate solutions: position, monitor, prep for imaging, notify stroke team. You evaluate: NIHSS trend, pupil checks, rebleed signs.

Not the most exciting part, but easily the most useful.

Miss one step in that chain and the patient deteriorates in the simulation — and on the unit Which is the point..

Real talk: I've watched new grads freeze on their first real stroke alert because they'd only ever seen it as a multiple-choice question. The case study is the rehearsal. Treat it like one Took long enough..

How the HESI Stroke Case Study Works

The scenario usually unfolds across six to eight tabs or screens. Don't rush. Read every tab before you answer anything. HESI hides critical data in the "History" or "Labs" tabs that changes the right answer on the "Interventions" tab.

Phase 1: Pre-Hospital / Triage

You'll get EMS report. Key data points:

• Time last known well (not "time symptoms started" — last known well)
• Cincinnati Prehospital Stroke Scale findings
• Blood glucose (hypoglycemia mimics stroke)
• Medications — especially anticoagulants, antiplatelets
• Allergies (contrast, tPA contraindications)

It sounds simple, but the gap is usually here That alone is useful..

Priority action here: Not IV access. Not labs. Rapid transport to stroke-capable facility with pre-notification. The clock started before you met the patient.

Phase 2: ED Arrival — The First 10 Minutes

At its core, where most points live or die.

First 10 minutes (per AHA/ASA guidelines):

1. General assessment + ABCs
2. NIH Stroke Scale (NIHSS) — by a certified examiner
3. Non-contrast CT head — stat
4. Blood glucose — fingerstick, immediate
5. IV access x2 — large bore
6. Labs: CBC, BMP, PT/INR, aPTT, troponin, lipid panel
7. 12-lead ECG — looking for afib, MI
8. Continuous cardiac monitoring + pulse oximetry

Notice what's not in the first 10 minutes: tPA decision. That comes after CT rules out hemorrhage and labs clear coagulation The details matter here. Practical, not theoretical..

Phase 3: The CT Result — Decision Fork

CT shows hemorrhage:

• Neurosurgery consult now
• Blood pressure management (usually SBP <140 for ICH, per guidelines)
• Reverse anticoagulation if applicable (vitamin K, PCC, idarucizumab for dabigatran, andexanet alfa for factor Xa inhibitors)
• No tPA. No anticoagulants. No antiplatelets.
• HOB 30 degrees (unless contraindicated) — reduces ICP

CT negative for blood (ischemic likely):

• Check tPA eligibility criteria — all of them
• Time window: ≤3 hours (standard) or ≤4.5 hours (extended criteria — age >80, anticoagulant use, NIHSS >25, diabetes + prior stroke, etc.)
• BP <185/110 before and during infusion
• Platelets >100k, INR <1.7, aPTT normal, glucose >50 and <400
• No recent surgery, trauma, GI bleed, arterial puncture at non-compressible site
• No current intracranial neoplasm, AVM, aneurysm

If eligible — **bolus then infuse tPA over 60 minutes.Plus, ** Stay at bedside. q15min neuro checks x2 hours, then q30min x6 hours, then q1hr x16 hours That's the whole idea..

If not eligible but within 24 hours and large vessel occlusion (LVO) on CTA — mechanical thrombectomy evaluation. Know the DAWN/DEFUSE-3 criteria: imaging mismatch, clinical deficit, time window up to 24 hours for select patients That's the part that actually makes a difference. No workaround needed..

Phase 4: Admission & First 24 Hours

This

Phase 4: Admission & First 24 Hours
Once the patient is admitted to a stroke unit or intensive care setting, the focus shifts from emergent reperfusion to vigilant monitoring, early complication prevention, and initiation of rehabilitative care.

1. Continuous Neurologic Surveillance – NIHSS is repeated at least every hour for the first 6 hours, then every 2–4 hours thereafter, with any new deficit triggering an immediate stat repeat head CT to rule out hemorrhagic transformation or edema.
2. Hemodynamic Management – Maintain systolic blood pressure <180/105 mm Hg (or <140/90 mm Hg if thrombolysis was given) for the first 24 hours, using labetalol, nicardipine, or clevidipine infusions as needed. Avoid both hypotension (which can worsen penumbral ischemia) and hypertension (which raises hemorrhage risk).
3. Metabolic Control – Keep serum glucose between 80–180 mg/dL; insulin sliding scales are preferred over bolus dosing to avoid hypoglycemia.
4. Temperature Regulation – Fever (>37.5 °C) worsens outcomes; administer acetaminophen and investigate sources (infection, central dysregulation). Therapeutic hypothermia is not routinely recommended outside of clinical trials.
5. Dysphagia Screening – Perform a validated bedside swallow assessment (e.g., Gugging Swallow Screen) before any oral intake; patients who fail should be kept NPO and referred to speech‑language pathology for a formal videofluoroscopic study.
6. Venous Thromboembolism Prophylaxis – Initiate subcutaneous low‑dose heparin or enoxaparin within 48 hours unless contraindicated by active hemorrhage or recent thrombolysis; intermittent pneumatic compression devices can be used immediately.
7. Pressure Injury Prevention – Turn the patient every 2 hours, use specialized mattresses, and keep skin clean and dry.
8. Early Mobilization & Rehabilitation – When neurologic status is stable, begin passive range‑of‑motion exercises within the first 24 hours, progressing to sitting at the edge of the bed and assisted standing as tolerated. Early involvement of physical, occupational, and speech therapists reduces length of stay and improves functional outcomes.
9. Cardiac Monitoring – Continue telemetry for at least 24 hours to detect atrial fibrillation, myocardial ischemia, or malignant arrhythmias that may have precipitated the stroke.
10. Patient & Family Education – Provide clear information about the stroke mechanism, treatment received, expected recovery trajectory, and warning signs of recurrence (e.g., sudden weakness, speech change, visual loss). Encourage questions and involve caregivers in discharge planning from day one.

Phase 5: Secondary Prevention & Discharge Planning
Before discharge, address modifiable risk factors to lower the chance of a recurrent event:

• Antithrombotic Therapy – For non‑cardioembolic ischemic stroke, initiate aspirin + clopidogrel for 21–30 days (if no contraindication) followed by long‑term monotherapy; for cardioembolic sources (e.g., atrial fibrillation), start oral anticoagulation (warfarin with target INR 2.0–3.0 or a DOAC) after ensuring no hemorrhagic transformation on follow‑up imaging.
• Blood Pressure Control – Aim for <130/80 mm Hg long‑term; initiate ACE‑inhibitor/ARB ± thiazide‑type diuretic unless contraindicated.
• Lipid Management – High‑intensity statin (atorvastatin 40–80 mg or rosuvastatin 20–40 mg) regardless of baseline LDL; consider adding ezetimibe if LDL remains >70 mg/dL.
• Lifestyle Modification – Smoking cessation, limited alcohol (<2 drinks/day for men, <1 for women), Mediterranean‑style diet, and aerobic activity ≥150 minutes/week.
• Diabetes Management – Target HbA1c <7 % (individualize based on comorbidities and hypoglycemia risk).
• Follow‑up Appointments – Neurology or stroke clinic within 1–2 weeks, primary care within 1 week, cardiology if arrhythmia detected, and rehabilitation services as needed.

Conclusion
Effective stroke care hinges on a seamless, time‑sensitive cascade that begins the moment EMS identifies a potential cerebrovascular event and extends well beyond the acute hospitalization. Rapid recognition, immediate

intervention, and evidence-based treatments, followed by vigilant monitoring and proactive risk factor modification. Here's the thing — by integrating rapid diagnostic protocols, thrombolytic eligibility assessments, and advanced neuroimaging, healthcare teams can minimize brain injury and optimize outcomes. Even so, ultimately, success depends on clear communication, patient education, and seamless coordination between emergency services, hospitals, and outpatient providers. Now, addressing modifiable risks such as hypertension, dyslipidemia, and diabetes, alongside lifestyle interventions, reduces recurrence while improving overall vascular health. Also, equally critical is the transition from acute care to rehabilitation and long-term prevention, where structured mobilization, cardiac surveillance, and multidisciplinary collaboration prevent complications and accelerate recovery. When executed effectively, this systematic approach not only saves lives but also preserves neurological function and enhances long-term quality of life, underscoring the importance of a unified, patient-centered strategy in stroke management It's one of those things that adds up..